Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tido Bajorat

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Thrombosis Research|September 4, 2019
Insights into neonatal thrombosisGili Kenet, Omri Cohen, Tido Bajorat, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|May 18, 2026
Extended Half-Life Factor Concentrates in Haemophilia TreatmentKatharina Holstein, Tido Bajorat, Rafael Beck, et al.
Blood Cells, Molecules & Diseases|January 20, 2022
Validation of a predictive model for identifying an increased risk for recurrence in adolescents and young adults with a first provoked thromboembolismVerena Limperger, Antje Torge, Bettina Kiesau, et al.
Blood Cells, Molecules & Diseases|December 18, 2020
Acquired von Willebrand syndrome in ECMO patients: A 3-year cohort studyBernd Panholzer, Tido Bajorat, Assad Haneya, et al.
Journal of Thrombosis and Thrombolysis|June 29, 2020
Role of prothrombin 19911 A>G polymorphism, blood group and male gender in patients with venous thromboembolism: Results of a German cohort studyVerena Limperger, Gili Kenet, Bettina Kiesau, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Thrombosis Research|September 4, 2019
Insights into neonatal thrombosisGili Kenet, Omri Cohen, Tido Bajorat, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|May 18, 2026
Extended Half-Life Factor Concentrates in Haemophilia TreatmentKatharina Holstein, Tido Bajorat, Rafael Beck, et al.
Blood Cells, Molecules & Diseases|January 20, 2022
Validation of a predictive model for identifying an increased risk for recurrence in adolescents and young adults with a first provoked thromboembolismVerena Limperger, Antje Torge, Bettina Kiesau, et al.
Blood Cells, Molecules & Diseases|December 18, 2020
Acquired von Willebrand syndrome in ECMO patients: A 3-year cohort studyBernd Panholzer, Tido Bajorat, Assad Haneya, et al.
Journal of Thrombosis and Thrombolysis|June 29, 2020
Role of prothrombin 19911 A>G polymorphism, blood group and male gender in patients with venous thromboembolism: Results of a German cohort studyVerena Limperger, Gili Kenet, Bettina Kiesau, et al.
Pageof 1